Press Release: Skila Launches Two New Solutions for Marketing and Medical Teams

Skila on Twitter

Press Release

Skila Launches Two New Solutions for Marketing and Medical Teams

Morris Plains, NJ, October 20, 2009 – Skila, A Sela2 Company, announces the launch of two new state-of-the-art solutions for facilitating launch preparation and clinical trial tracking in the life science industry. These new solutions have two goals in mind: 1) providing users with knowledge agility by offering the software, processes and services to help pharmaceutical companies achieve their bottom line, and 2) rapid deployment, typically from concept to utilization in less than 6 weeks.

Skila’s Launch Readiness™ offers a single touchpoint for facilitating launch preparation and readiness activities across the globe. Skila’s iLaunch Readiness™ solution ensures transparency, compliance and real-time knowledge by enabling launch teams to quickly understand:

What needs to be done by key deliverables
Who is responsible
When is it due
What is the status and why
What action is being taken

Skila’s Clinical Trial Tracker™ offers faster insight and sharing of knowledge regarding performance of clinical trials for medical affairs teams. Clinical Trial Tracker™ integrates clinical trial data from disparate systems, reduces manual processes and increases transparency.

“We are very excited about the launch of these two new solutions, Launch Readiness™ and Clinical Trial Tracker™,” says Susan Dorfman, VP Global Marketing and Alliance Management, Skila. “The new solutions will enable product launch and medical teams to quickly understand where they stand with their product launch and clinical trial activities.”

About Skila

Skila, a BelHealth investment company, is a global technology and services company specializing in fully managed "Solution" as-a-Service (SaaS) product launch lifecycle management and engagement / relationship management solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams that include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.

Having developed strong relationships with a broad number of global pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and more than 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the exponential growth and adoption of our methodology, technology and continuous services as the business platform of choice for our clients.

BelHealth is a private healthcare investment fund. For more info, visit www.belhealth.com.

To receive more information:

Do You Skila?